1. Market Research
  2. > Pharmaceutical Market Trends
Muscle Relaxants Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Muscle Relaxants Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • August 2018
  • 100 pages
  • ID: 5566892
  • Format: PDF
  • By Infinium

Summary

Table of Contents

The report on global muscle relaxants drugs market provides qualitative and quantitative analysis for the period of 2016 to 2024.

The report predicts the global muscle relaxants drugs market to grow with a CAGR of 6.2% over the forecast period of 2018-2024. The study on muscle relaxants drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
Increasing stress and tension levels among people due to work pressure, improper sleep, rising accidents and advance drug delivery technologies are some of the factors fueling the growth of muscle relaxants drug market. The online shopping of muscle relaxants are helping to increase the demand for muscle relaxant drugs. In addition, adoption of facial relaxants for anti-aging treatment is boosting the market growth. However, side effects caused by the muscle relaxants drugs hinders the market growth. Use of muscle relaxant drugs in different applications and rising usage in cosmetic industry can create a demand for muscle relaxant market in near future.
Geographically, North held the largest market share in 2017. The factors such as increase awareness about muscle relaxant drugs, adoption of online shopping for drugs are the factors driving growth in this region. Asia Pacific is expected to be the fastest growing CAGR among other regions owing to huge population base, rising stress/ tension level and improving healthcare infrastructures in this region.

Recent developments:-
Beximco Pharmaceuticals launched methocarbamol(500 mg and 700 mg) product for US market
In April 2018, Beximco Pharmaceuticals launched its third product Methocarbamol (500mg and 700mg) to the US market. A subsidiary of Beximco Group, it is the largest private business group in Bangladesh. The foundation of this Group was laid by two brothers – ASF Rahman and Salman F Rahman. Beximco Pharmaceuticals is the largest exporter of pharmaceuticals in Bangladesh. It manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients (API) and intravenous (IV) fluids. The latest product that Beximco Pharmaceuticals has decided to export to US is Methocarbamol, is generic equivalent to muscle relaxant drug Robaxin from Auxilium Pharmaceuticals.
Dr Reddy’s launched anti-depressant, muscle relaxant tablets in US
In September 2017, Dr Reddy’s Laboratories Limited launched anti depressant, Bupropion Hydrochloride Extended Release Tablets, 150 mg and 300 mg, as well as muscle relaxant drug Metaxalone in the US market. The anti-depressant drug is a generic equivalent version of Wellbutrin XL, a trademark of GlaxoSmithKline LLC. However, the generic version of Welbutrin SR (100 mg, 150 mg and 200 mg) is being sold by Dr Reddy’s since September 2016. Metaxalone, which is used for the treatment of skeletal muscle conditions such as pain and injury, is a generic equivalent version of the Skelaxin brand of King Pharmaceuticals Research and Development, Inc.
Beximco’s muscle relaxant drug got approval for US market
In July 2017,Beximco Pharma’s muscle relaxant drug Methocarbamol has been cleared for the United States. The Bangladesh drug maker said in a statement on Monday that it received approval from the US Food and Drug Administration or FDA. This is the fourth product approval for Beximco in the US market and it expects to launch the product during last quarter of 2017, according to the statement. The company said there were four active generic players for Methocarbamol in the USA -- Camber, Qualitest, West-Ward and Solco. "I firmly believe this approval and our growing pipeline for US will largely help us build our presence in the world’s largest pharma market in the coming years,” said Beximco Pharma’s Managing Director Nazmul Hassan. In 2015, Beximco Pharma became the first Bangladeshi drug maker to be audited and approved by the FDA. It currently has a global footprint in more than 50 countries.

The report on muscle relaxants drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global muscle relaxants drugs market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global muscle relaxants drugs market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global muscle relaxants drugs market is segmented on the basis of drugs type and distribution channel.

Global Muscle Relaxants Drugs Market by Drugs Type
- Facial Muscle Relaxant Market
- Skeletal Muscle Relaxant Market
- Neuromuscular Relaxant Market
Global Muscle Relaxants Drugs Market by Distribution Channel
- Drug Stores
- Hospitals
- Clinics
- Online Stores

Company Profiles
- Abbott Laboratories
- Mallinckrodt plc.
- Medtronic Neuromodulation (Medtronic Inc.)
- Vertical Pharmaceuticals LLC
- Johnson & Johnson
- Par Sterile Products, LLC.
- Endo Pharmaceuticals, Inc.
- SteriMax Inc.
- Upsher Smith Laboratories, Inc.
- Orient Pharma Co., Ltd.

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of muscle relaxants drugs market .
2. Complete coverage of all the segments in muscle relaxants drugs market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global muscle relaxants drugs market . The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($4795)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on